Suchergebnisse - "Nakazawa, Youya"

PubPharm (16)

1

Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models

enthalten in: Nature communications | 2024

von Nakazawa, Y. | Miyano, M. | Tsukamoto, S. | +15

2

ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs

enthalten in: Molecular cancer therapeutics | 2023

von Tsukamoto, S. | Sugi, N. | Nishibata, K. | +20

3

Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer

enthalten in: Scientific reports | 2018

von Nakazawa, Y. | Taniyama, Y. | Sanada, F. | +5

4

Multitargeting strategy using lenvatinib and golvatinib : maximizing anti-angiogenesis activity in a preclinical cancer model

enthalten in: Cancer science | 2015

von Nakazawa, Y. | Kawano, S. | Matsui, J. | +5

5

Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor

enthalten in: Cancer science | 2014

von Nakagawa, T. | Matsushima, T. | Kawano, S. | +9

6

Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway‐induced resistance to vascular endothelial growth factor receptor inhibitor

enthalten in: Cancer science | 2014

von Nakagawa, T. | Matsushima, T. | Kawano, S. | +9

7

Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies

enthalten in: Cancer science | 2011

von Nakazawa, Y. | Takagi, S. | Sato, S. | +5

8

Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti‐Aggrus/podoplanin antibodies

enthalten in: Cancer science | 2011

von Nakazawa, Y. | Takagi, S. | Sato, S. | +5

9

The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis

enthalten in: Cancer research | 2011

von Nakazawa, Y. | Arai, H. | Fujita, N.

10

The Novel Metastasis Promoter Merm1/Wbscr22 Enhances Tumor Cell Survival in the Vasculature by Suppressing Zac1/p53-Dependent Apoptosis

enthalten in: Cancer research | 2011

von Nakazawa, Y. | Arai, H. | Fujita, N.